Onego Bio

Onego Bio is a US-Finnish food-biotech company revolutionizing the food system by harnessing the power of precision fermentation to manufacture real egg protein entirely animal-free. Their ingredient, Bioalbumen, sets a new standard for sustainable protein with identical taste and nutrition, superior functional properties, and over 90% smaller environmental footprint compared to eggs from chickens. Onego’s highly productive and scalable technology caters to the needs of the food industry searching for stable, sustainable functional ingredients. As a game-changer in the field, the company was selected as the Winner of Fast Company’s 2023 World Changing Ideas awards and is a co-founder of two industry associations: Precision Fermentation Alliance and Food Fermentation Europe.

Onego Bio headquartered in Europe, operates in the Biotechnology, Food and Beverage, Manufacturing sector. The company focuses on Biotechnology and has secured $4.3B in funding across 60 round(s). With a team of 11-50 employees, Onego Bio is actively contributing to advancements in Biotechnology. Their latest funding round, Venture Round - Onego Bio, raised $15.3M. Discover more about their projects, partnerships, and impact on our platform.